Volume 12, Issue 2 (Spring 2023)
aumj 2023, 12(2): 109-115 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mehrpour tarhani F, Ramezani M, Almasi A, Hematti M, Amirian F. Epidemiologic survey and clinic-pathologic assessment of endometrial cancer in Kermanshah during 2013-2018. aumj 2023; 12 (2) :109-115
URL: http://aums.abzums.ac.ir/article-1-1699-en.html
URL: http://aums.abzums.ac.ir/article-1-1699-en.html
Fatemeh Mehrpour tarhani1 
, Mazaher Ramezani *2 , Afshin Almasi3 , Maryam Hematti4 , Farhad Amirian5
, Mazaher Ramezani *2 , Afshin Almasi3 , Maryam Hematti4 , Farhad Amirian5
1- General Practitioner, Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran-Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
2- Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran-Associate Professor of Dermatopathology, Molecular Pathology Research Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
3- Assisstant Professor of Biostatistics, Clinical Research Development Center, Imam Khomeini, Mohammad Kermanshahi, Farabi Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
4- Master of Statistics, Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
5- Pathologist, Molecular Pathology Research Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
2- Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran-Associate Professor of Dermatopathology, Molecular Pathology Research Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
3- Assisstant Professor of Biostatistics, Clinical Research Development Center, Imam Khomeini, Mohammad Kermanshahi, Farabi Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
4- Master of Statistics, Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
5- Pathologist, Molecular Pathology Research Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
Abstract: (727 Views)
Background: Endometrial cancer is the most common gynecological cancer and accounts for six percent of malignancies in women. The aim of this study was evaluation of epidemiology of this cancer and clinico-pathologic characteristics of patients in west of Iran.
Materials and Methods: Forty four patients with endometrial malignancy referred to Imam Reza hospital in Kermanshah were included in this descriptive-cross sectional study. Data was extracted from archive files and pathology reports in the hospital.
Results: The mean age of patients was 56.95+/_ 11.31 years and the majority were in the age range of 50-60 years. None of the patients had a history of tamoxifen therapy, oligomenorrhea, late menopause and premature menarche, infertility or alcohol use. The majority of patients had no family history of endometrial cancer (90.9%). A family history of endometrial adenocarcinoma was observed in only 4 patients. Endometrial adenocarcinoma (88.6%) and endometrial stromal sarcoma (11.4%) were the most common endometrial cancers in patients, respectively. Vaginal bleeding was reported as the most common clinical symptom in the majority of patients. The age distribution of patients showed that patients under the age of 60 years and also more than 60 years are mostly diagnosed with endometrial adenocarcinoma.
Conclusion: Endometrial adenocarcinoma is the most common endometrial malignancy in west of Iran, that mainly is presented in the sixth decade with vaginal bleeding. This cancer showed no obvious association with known risk factors in west of Iran.
Materials and Methods: Forty four patients with endometrial malignancy referred to Imam Reza hospital in Kermanshah were included in this descriptive-cross sectional study. Data was extracted from archive files and pathology reports in the hospital.
Results: The mean age of patients was 56.95+/_ 11.31 years and the majority were in the age range of 50-60 years. None of the patients had a history of tamoxifen therapy, oligomenorrhea, late menopause and premature menarche, infertility or alcohol use. The majority of patients had no family history of endometrial cancer (90.9%). A family history of endometrial adenocarcinoma was observed in only 4 patients. Endometrial adenocarcinoma (88.6%) and endometrial stromal sarcoma (11.4%) were the most common endometrial cancers in patients, respectively. Vaginal bleeding was reported as the most common clinical symptom in the majority of patients. The age distribution of patients showed that patients under the age of 60 years and also more than 60 years are mostly diagnosed with endometrial adenocarcinoma.
Conclusion: Endometrial adenocarcinoma is the most common endometrial malignancy in west of Iran, that mainly is presented in the sixth decade with vaginal bleeding. This cancer showed no obvious association with known risk factors in west of Iran.
Type of Study: Research |
Subject:
Special
Received: 2022/05/16 | Accepted: 2023/03/06 | Published: 2023/05/31
Received: 2022/05/16 | Accepted: 2023/03/06 | Published: 2023/05/31
References
1. Hamidi Layen A, Yousefi Z, Davachi B, Hosein Jafarian A, Morovatdar N, Azimi H, et al. Epidemiological findings and risk factors for endometrial cancer patients .JOGI.2019; 22(1):20-25.
2. Felix AS, Yang HP, Bell DW, Sherman ME. Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences. Adv Exp Med Biol. 2017;943:3-46. [DOI:10.1007/978-3-319-43139-0_1]
3. Suidan RS, He W, Sun CC, Zhao H, Fleming ND, Ramirez PT, et al. Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia. Gynecol Oncol. 2017 Apr;145(1):55-60. [DOI:10.1016/j.ygyno.2017.01.025]
4. Rezaianzadeh, A., Dehghani, S., Mousavi, M., Rezaeia-nzadeh, R. The Incidence of Uterus Cancer in Iran: A Systematic Review. Women's Health Bulletin 2017; 4(1): 1-4. [DOI:10.17795/whb-42917]
5. Kadkhodayan S, Maleki A, Hasanzadeh M, Yousefi Z. Prevalence of endometrial cancer in young patients. Tehran Univ Med J. 2018; 76 (5) :331-337.
6. Savelli L, Testa AC, Mabrouk M, Zannoni L, Ludovisi M, Seracchioli R, et al. A prospective blinded comparison of the accuracy of transvaginal sonography and frozen section in the assessment of myometrial invasion in endometrial cancer. Gynecol Oncol. 2012; 124(3):549-52. [DOI:10.1016/j.ygyno.2011.11.016]
7. Andarieh MG, Delavar MA, Moslemi D, Esmaeilzadeh S. Risk factors for endometrial cancer: results from ahospital-based case-control study. Asian Pac J Cancer Prev. 2016; 17(10):4791.
8. Yeganeh, Z., Sheikhan, Z., Kariman, N., Hajian, P., Nasiri, M. Relationship between gestational diabetes and endometrial cancer. The Iranian Journal of Obstetrics, Gynecology and Infertility 2019; 22(3): 49-58.
9. Yazdani S, Bouzari Z, Abedi samakoush M, Naeimi rad M. Epidemiology of Endometrial Cancer in North of Iran. Basic Clin Cancer Res. 8(4):37-41.
10. Arab M, Noghabaei G. Comparison of Age- Standard Incidence Rate Trends of Gynecologic and Breast Cancer in Iran and Other Countries. Iran J Public Health 2014;43(10):1372-1379.
11. Aune D, Sen A, Vatten LJ. Hypertension and the risk of endometrial cancer: a systematic review and metaanalysis of case-control and cohort studies. Sci Rep. 2017; 7:44808. [DOI:10.1038/srep44808]
12. Lucenteforte E, Bosetti C, Talamini R, Montella M, Zucchetto A, Pelucchi C, et al. Diabetes and endometrial cancer: effect modification by body weight, physical activity and hypertension. Br J Cancer 2007; 97(7):995-8. [DOI:10.1038/sj.bjc.6603933]
13. Parazzini F, La Vecchia C, Negri E, Riboldi GL, Surace M, Benzi G, et al. Diabetes and endometrial cancer: an Italian case‐control study. Int J Cancer 1999; 81(4):539-42.
https://doi.org/10.1002/(SICI)1097-0215(19990517)81:4<539::AID-IJC6>3.0.CO;2-Q [DOI:10.1002/(SICI)1097-0215(19990517)81:43.0.CO;2-Q]
14. Shrivastava S, Barmon D, Kataki AC, Deka P, Sharma JD, Choudhary BK, et al. Magnetic resonance imagingin pre-operative staging of endometrial cancer. Indian J Cancer 2016; 53(1):181-5. [DOI:10.4103/0019-509X.180859]
15. Banno K., Yanokura M., Kobayashi Y., Kawaguchi M., Nomura H., Hirasawa A., et al. Endometrial cancer as a familial tumor: pathology and molecular carcinogenesis (review). Curr Genomics 2009;10(2):127-132. [DOI:10.2174/138920209787847069]
16. Hamet P. Cancer and hypertension: a potential for crosstalk. J Hypertens. 1997; 15(12 Pt 2):1573-7. [DOI:10.1097/00004872-199715120-00058]
17. Rossi R, Turco V, Origliani G, Modena MG. Type 2 diabetes mellitus is a risk factor for the development of hypertension in postmenopausal women. J Hypertens. 2006; 24(10 ):2017-22. [DOI:10.1097/01.hjh.0000244951.72664.4b]
18. Gelber RP, Gaziano JM, Manson JE, Buring JE, Sesso HD. A prospective study of body mass index and the risk of developing hypertension in men. Am J Hypertens. 2007; 20(4):370-7. [DOI:10.1016/j.amjhyper.2006.10.011]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
